Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms (Q46585287)
scientific article published in January 2005
Language:
(P31) (Q13442814)
(P304) 253-259
(P407) (Q1860)
(P433) 3
(P478) 8
(P577) Saturday, January 1, 2005
(P921) (Q218507)
(P1433) (Q2108326)
(P1476) "Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms" (language: en)
(P2093) Quinn JE
Brown LG
Zhang J
Keller ET
Vessella RL
Corey E
(P2860) (Q67946292)
(Q43843519)
(Q39946634)
(Q74837359)
(Q40538169)
(Q32034470)
(Q34247922)
(Q37358267)
(Q43791653)
(Q34247917)
(Q24313918)
(Q24603266)
(Q39116155)
(Q34325803)
(Q41687961)
(Q78052193)
(Q40621823)
(Q34216753)
(Q38345295)
(Q45713487)
(Q81323685)
other details
description scientific article published in January 2005

External Links